Skip to content
Search

Latest Stories

RCGP urges NHS England to confirm TERS funding for 2025/26

TERS funding 2025-26
TERS scheme attract GP trainees to economically disadvantaged areas (gettyimages)

With the vital funding yet to be confirmed, the College fears there is a “real danger” that it could be cut from April  

The Royal College of GPs (RCGP) has warned that patients in deprived areas could face even greater difficulty accessing GP services if funding for the Targeted Enhanced Recruitment Scheme (TERS) is withdrawn.

In a letter to NHS England, the College is calling for confirmation that TERS will be extended for 2025/26 and beyond.


The scheme, launched in 2016, was designed to attract GP trainees to economically disadvantaged areas, where healthcare provision has historically been inadequate.

TERS offers a one-off payment of £20,000 to GP trainees who commit to working in hard-to-recruit-to locations.  Over the years, the scheme has successfully recruited over 2,000 GPs.

However, with funding for 2025/26 yet to be confirmed, the RCGP is worried that it could be cut from April.

The College has expressed concern that discontinuing the scheme could “make it even more difficult to recruit GPs to work in deprived and under-doctored areas where patients are already significantly disadvantaged compared to those in more affluent areas of the country.”

Highlighting the UK-wide workforce crisis, RCGP pointed out that in the most deprived areas of England, there are 2,450 patients per full time, fully qualified GP – over 300 more patients per GP than in more affluent areas of the country.

The areas with the highest numbers of places available through the TERS scheme in 2024/25 were Durham and Tees Valley (60), Dewsbury, Pontefract & Wakefield (47) and Sherwood Forest (36).

Professor Kamila Hawthorne, chair of the RCGP, expressed her concerns: “It’s alarming to see a scheme that has provided our patients with much-needed access to GPs now under threat.”

“The TERS has successfully attracted thousands of GP trainees to work in areas that they might previously not have considered, and which desperately need more GPs.

“It has led to clear benefits, including improved patient access, continuity of care, and long-term workforce retention.”

Hawthorne emphasised that cutting the scheme would be a “major step backwards” for the government’s manifesto commitment to halve the gap in healthy life expectancy across the UK.

She noted that the scheme not only encourages GP trainees to take roles in more deprived areas of the country but also put down roots and become part of the community.

“The continuation of TERS is important if we are to attract and retain GPs in these areas and truly tackle health inequalities for our patients,” she added.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less